Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Maze Therapeutics (MAZE) Leases (2024 - 2025)

Maze Therapeutics has reported Leases over the past 2 years, most recently at $20.1 million for Q4 2025.

  • Quarterly Leases fell 13.48% to $20.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.1 million through Dec 2025, down 13.48% year-over-year, with the annual reading at $20.1 million for FY2025, 13.48% down from the prior year.
  • Leases was $20.1 million for Q4 2025 at Maze Therapeutics, down from $20.9 million in the prior quarter.
  • Over five years, Leases peaked at $23.2 million in Q4 2024 and troughed at $20.1 million in Q4 2025.